A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors. Hook C, Chatterjee U, Sheng H, Zhu Q, et al. NPJ Breast Cancer 2024;10:9.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hook C, Chatterjee U, Sheng H, Zhu Q, et al. A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors. NPJ Breast Cancer 2024;10:9.
PMID: 38245540